Tom McKillop

Tom McKillop is a Scottish chemist and business executive, best known for his roles as CEO of AstraZeneca and Chairman of the Royal Bank of Scotland (RBS).

Early Life and Education

McKillop was born in Lanarkshire, Scotland. He attended the University of Edinburgh, where he earned a Bachelor of Science degree in Chemistry. He later received a PhD in Chemistry from the same institution.

Career

AstraZeneca

McKillop began his career at ICI Pharmaceuticals, which later became part of Zeneca. He held various positions within the company, including Director of Research. In 1999, Zeneca merged with Astra AB to form AstraZeneca, and McKillop was appointed CEO. Under his leadership, AstraZeneca developed several successful drugs, including Crestor and Nexium.

Royal Bank of Scotland

In 2006, McKillop transitioned to the financial sector, becoming Chairman of the Royal Bank of Scotland. His tenure was marked by the bank's near-collapse during the 2008 financial crisis, which led to a controversial government bailout.

Controversies

McKillop faced criticism for his role in the RBS crisis, particularly for his decision to approve the bank's ill-fated acquisition of ABN AMRO. He resigned as Chairman in 2009.

Honours

In recognition of his contributions to the pharmaceutical industry, McKillop was knighted in 2002. He is also a Fellow of the Royal Society of Edinburgh and the Royal Society of Chemistry.

Personal Life

McKillop is married with three children. He is a keen golfer and supporter of Celtic FC.

See Also

• AstraZeneca
• Royal Bank of Scotland
• 2008 financial crisis

References

<references />

   This article is a United Kingdom business-related biographical stub. You can help WikiMD by expanding it!

   This article is a Scottish biographical stub. You can help WikiMD by expanding it!